Clinical Trial Manager for the GRACE study

Application deadline:

ISGlobal is seeking an experienced Clinical Trial Manager who is interested in taking over and managing activities of the clinical trial “A Phase III, randomized, double-blind, placebo-controlled multi-country study to demonstrate efficacy of a single dose of unadjuvanted respiratory syncytial virus (RSV) Maternal vaccine, administered IM to pregnant women 18 to 49 years of age, for prevention of RSV associated lower respiratory tract infections (LRTI) in their infants up to 6 months of age” (GRACE). The GRACE trial will be conducted at the Maternity of Hospital Clinic, one of the participating sites of this multicenter international trial, and will enrol pregnant women and their newborns. This study will be co-led by ISGlobal and Hospital Clínic.
The primary objective of this trial is to assess the efficacy of a single dose of the RSV Maternal vaccine administered to maternal participants in preventing medically assessed, RSV-associated severe (including very severe) LRTIs in their infant participants up to 6 months of age. GRACE is a 30 months study funded by GSK.